Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction

被引:13
|
作者
Di Lazzaro, Giulia [1 ]
Schirinzi, Tommaso [1 ]
Giambrone, Maria Pia [1 ]
Di Mauro, Roberta [2 ]
Palmieri, Maria Giuseppina [1 ]
Rocchi, Camilla [1 ]
Tinazzi, Michele [3 ]
Mercuri, Nicola Biagio [1 ,4 ]
Di Girolamo, Stefano [2 ]
Pisani, Antonio [1 ,4 ]
机构
[1] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy
[2] Univ Roma Tor Vergata, Dept Otorhinolaryngol, Rome, Italy
[3] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy
[4] Fdn Santa Lucia IRCCS, Rome, Italy
关键词
EVOKED MYOGENIC POTENTIALS; BRAIN-STEM; PATHOPHYSIOLOGY; IMPAIRMENT;
D O I
10.1155/2018/8673486
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Pisa syndrome (PS) is a postural complication of Parkinson's disease (PD). Yet, its pathophysiology remains unclear, although a multifactorial component is probable. Cervical vestibular evoked myogenic potentials (cVEMPs) explore vestibulospinal pathway, but they have not been measured yet in PD patients with PS (PDPS) to assess a potential vestibular impairment. Materials and Methods. We enrolled 15 PD patients, 15 PDPS patients, and 30 healthy controls (HCs). They underwent neurological examination and were examined with Unified Parkinson's Disease Rating Scale II-Ill (UPDRSII-III), audiovestibular workup, and cVEMP recordings. Data were analysed with Chi-square, one-way ANOVA, multinomial regression, nonparametric, and Spearman's tests. Results. cVEMPs were significantly impaired in both PD and PDPS compared with HCs. PDPS exhibited more severe cVEMP abnormalities with prevalent bilateral loss of potentials, compared with the PD group, in which a prevalent unilateral loss was instead observed. No clinical-neurophysiological correlations emerged. Conclusions. Differently from HC, cVEMPs are altered in PD. Severity of cVEMPs alterations increases from PD without PS to PDPS, suggesting an involvement of vestibulospinal pathway in the pathophysiology of PS. Our results provide evidence for a significant impairment of cVEMPs in PDPS patients and encourage further studies to test validity of cVEMPs as diagnostic and prognostic biomarkers of PD progression.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Concomitant Appearance of Pisa Syndrome and Striatal Hand in Parkinson's Disease
    Pandey, Sanjay
    Mehndiratta, Manmohan
    JOURNAL OF MOVEMENT DISORDERS, 2011, 4 (02) : 78 - 79
  • [32] Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy
    Fasano, Alfonso
    Di Matteo, Alessandro
    Vitale, Carmine
    Squintani, Giovanna
    Ferigo, Laura
    Bombieri, Federica
    Santangelo, Gabriella
    Amboni, Marianna
    Barone, Paolo
    Tinazzi, Michele
    MOVEMENT DISORDERS, 2011, 26 (14) : 2578 - 2580
  • [33] Pisa Syndrome in Parkinson's Disease: Electromyographic Aspects and Implications for Rehabilitation
    Frazzitta, Giuseppe
    Balbi, Pietro
    Gotti, Francesco
    Maestri, Roberto
    Sabetta, Annarita
    Caremani, Luca
    Gobbi, Laura
    Capobianco, Marina
    Bera, Rossana
    Giladi, Nir
    Ferrazzoli, Davide
    PARKINSONS DISEASE, 2015, 2015
  • [34] Effect of electroacupuncture for Pisa syndrome in Parkinson’s disease:A case report
    Wei-Jing Lu
    Jing-Qi Fan
    Ming-Yue Yan
    Keiko Mukaeda
    Li-Xing Zhuang
    Li-Li Wang
    World Journal of Clinical Cases, 2022, 10 (30) : 11023 - 11030
  • [35] Pisa syndrome in Parkinson's disease: Clinical, electromyographic, and radiological characterization
    Tassorelli, Cristina
    Furnari, Anna
    Buscone, Simona
    Alfonsi, Enrico
    Pacchetti, Claudio
    Zangaglia, Roberta
    Pichiecchio, Anna
    Bastianello, Stefano
    Lozza, Alessandro
    Allena, Marta
    Bolla, Monica
    Sandrini, Giorgio
    Nappi, Giuseppe
    Martignoni, Emilia
    MOVEMENT DISORDERS, 2012, 27 (02) : 227 - 235
  • [36] Pisa Syndrome in Parkinson's Disease Is Associated With Specific Cognitive Alterations
    Artusi, Carlo Alberto
    Montanaro, Elisa
    Tuttobene, Sara
    Romagnolo, Alberto
    Zibetti, Maurizio
    Lopiano, Leonardo
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [37] Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease
    F. Valentino
    G. Cosentino
    B. Fierro
    S. Realmuto
    S. Mastrilli
    G. Savettieri
    M. D’Amelio
    Neurological Sciences, 2015, 36 : 2305 - 2305
  • [38] PISA SYNDROME IN PARKINSON'S DISEASE-A MOBILE OR FIXED DEFORMITY?
    Doherty, Karen
    Davagnanam, Indran
    Molloy, Sean
    Silveira-Moriyama, Laura
    Lees, Andrew
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [39] Reversible Pisa syndrome in patients with Parkinson’s disease on dopaminergic therapy
    A. Cannas
    P. Solla
    G. Floris
    P. Tacconi
    A. Serra
    M. Piga
    F. Marrosu
    M. G. Marrosu
    Journal of Neurology, 2009, 256 : 390 - 395
  • [40] Visuospatial deficits characterize Pisa syndrome and not Camptocormia in Parkinson's disease
    Artusi, C. A.
    Montanaro, E.
    Erro, R.
    Margraf, N.
    Geroin, C.
    Spagnolo, F.
    Pilotto, A.
    Magistrelli, L.
    Marchet, A.
    Zibetti, M.
    Comi, C.
    Padovani, A.
    Tinazzi, M.
    Lopiano, L.
    MOVEMENT DISORDERS, 2022, 37 : S528 - S528